Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman represents Underwriter Maxim Group LLC in the Closing of $10.3 Million Offering with GeoVax Labs, Inc.

GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, closed its offering of 1,644,000 shares of its common stock, which included 204,000 shares sold pursuant to the full exercise of the underwriter’s option to purchase additional shares, at a price to the public of $6.25.  The gross proceeds from the offering were approximately $10.3 million.

Lucosky Brookman assisted its client, Maxim Group LLC, as underwriter’s counsel.  Maxim Group acted as the sole book-running manager for the offering. 

The offering was conducted pursuant to the Company’s registration statement on Form S-3, previously filed with and subsequently declared effective by the Securities and Exchange Commission.